疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

6 ~( d% |3 x  x" O5 B

Vaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
- T6 T% m/ U  r0 X% |+ K; q* D
SECTION 1: General aspects of vaccination
/ ]/ o6 Y' Z0 H1 |8 l; m) m1 A short history of vaccination 1
) f+ B& r4 B) k/ `5 J7 p, X. M2 Vaccine immunology 14
4 Q: v; g& W/ c2 S1 J+ `0 _1 c) t3 The vaccine industry 33
4 Vaccine manufacturing 44
: H1 V+ b7 t3 t5 Evolution of adjuvants across the centuries 58
; B& q* e) o* M8 ~) e6 Vaccine additives and manufacturing residuals in the United States:
9 ?1 m+ ~$ Q" ulicensed vaccines 71
( E' {8 F0 h* K; o7 f7 Passive immunization 80
- E0 \2 `" @& |: Y8 General immunization practices 88
SECTION 2: Licensed vaccines
- t- f: ?4 |5 i/ N9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
) x) x' H1 l; V14 Hepatitis A vaccines 183
7 [1 d% B1 s# I15 Hepatitis B vaccines 205
; k0 {4 D, h7 s# k, F6 i16 Human papillomavirus vaccines 235
9 h' b; ]4 [3 i4 z1 v17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
. I0 Y/ D: [% }. |19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
8 q4 ~, n/ L5 |& r2 j5 F7 o) h21 Meningococcal vaccines 388
9 s, v0 Q1 Y6 @3 \22 Mumps vaccine 419
- D- d- e# a; `8 s6 q7 ]( S+ A7 O23 Pertussis vaccines . 447
- m0 _& q, P8 ]5 v, Y/ T24 Plague vaccines 493
5 o' T% o  Q: j- P: [25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
7 c8 F0 F1 e6 U8 W  R- ]28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
31 Rubella vaccine 688
32 Smallpox and vaccinia 718
7 L$ r+ l  Z# y  O' q6 B33 Tetanus toxoid 746
" D7 Y, ]7 x  P3 v7 o34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
) \' B4 i3 t5 d. j36 Typhoid fever vaccines 812
37 Varicella vaccine 837
4 ]$ |: k8 c; `* w  p1 V38 Yellow fever vaccine 870
39 Zoster vaccine 969
. Z5 ?$ g; O& [$ l40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
9 m) C1 H: N6 X% N41 Biodefense and special pathogen vaccines 1008
( V4 i! ?/ S  P; N: H42 Therapeutic cancer vaccines 1018
: ~' q9 a2 W% c- a& s) w43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
+ L3 a, a, t) c- ?* _, \5 H( i2 V45 Diarrhea caused by bacteria 1052
4 h: |& M9 S7 E. X0 [46 Ebola vaccine 1060
7 c1 g- n0 M: g  b% \47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
1 s2 R& S: @4 M  w49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
- T! U- H1 K) R; d51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
2 X5 [/ o* U7 D  i4 V) R53 Malaria vaccines 1133
0 e6 x7 N4 Q! L8 I2 f6 C54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
# ]8 t0 l: A9 D5 n, J57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
& D; e( U7 c( T, |4 q59 Streptococcus group B vaccines 1176
8 L3 p0 o* ]! I0 y60 Technologies for making new vaccines 1182
: H7 ~7 @) y1 f. g; I% ]  v# p. P61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
9 }7 B# {) @& v! X  X3 a; C63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
0 l' f+ t  E. G: E9 a3 s65 Vaccines for international travel 1270
7 z" [7 S, B/ I6 F66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
6 s  x5 z+ U0 J2 a3 M: E67 Immunization in the United States 1310
) f7 C/ q7 L: \7 v* ~68 Immunization in Europe . 1334
& L+ ], ~% ~4 a  _  ?: d& s: f69 Immunization in the Asia-Pacific region 1353
1 n7 e+ F8 s/ S. r! _/ r70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
1 N9 s5 T; G; I, ]74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
, G) P) ^* A3 g" s+ h76 Vaccine safety 1464
  h1 G9 A, i4 n: S77 Legal issues . 1481
78 Ethics 1508

- G5 s( V/ b2 c1 ^
( o- v$ c( w5 J

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

  F& @7 L0 p; E7 M1 O8 PVaccines, 6th Edition

+ O6 Q$ o/ v3 ~: @" XApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link? ... 1&uk=3810996606
  |( X/ H( w- N, t$ C0 Z
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
. n' n% J1 q0 D9 B" S- X2 [2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
! h) j  F! D$ d; w% n* g3 c9 J2 a. r6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
) P- U, j8 c6 e1 ^# Y8 A8 ?6 p7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
7 T+ r: ~' H7 K5 N) P# Q10 Anthrax vaccines 127
11 Cholera vaccines 141
0 |. l! A: {! @0 }4 J: e12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
6 p& Q9 }/ Z; @# F! f/ n1 K0 r  y14 Hepatitis A vaccines 183
* N( J: `. [7 g: i9 a15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
8 N$ |) \0 M& G5 w# Z; F; T. T17 Inactivated influenza vaccines 257
6 ?7 N, o) M- P* g& i$ Q$ C18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
% c! b# b( S5 f. J" O, Y23 Pertussis vaccines . 447
6 r' l: q  U: v  n/ W0 R; ^24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
) ^* K1 J* j( k' N* D29 Rabies vaccines .646
30 Rotavirus vaccines . 669
; w% s$ H7 U) h31 Rubella vaccine 688
, y& ]: J/ h' V; b4 \# f- T32 Smallpox and vaccinia 718
5 v$ U" Y( t' |5 i33 Tetanus toxoid 746
7 V/ }% c: D- K6 `( G34 Tick-borne encephalitis virus vaccines 773
) F# O( R* D3 j6 W& y& m# i: J35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
& x7 [/ t- f% D, z; \1 K1 l. ~38 Yellow fever vaccine 870
39 Zoster vaccine 969
' z! x+ y9 W, y7 P40 Combination vaccines 981
* Y* Y+ F3 k3 q+ R2 i; C/ d9 LSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
9 R- s4 v, _/ u5 T6 X) Z2 ~% J44 Dengue vaccines 1042
; j; C* I; {' S45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
: c5 [4 ?# F7 _( }! Z( U) Q$ _49 Hepatitis E vaccines 1085
* U" u) B$ W. t50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
8 c2 [8 j: s& @; C( Y53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
$ b% l9 p3 V$ b1 R9 r55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
" ^% I" L4 }; S0 v  ~, N% T56 Parasitic disease vaccines 1154
) S$ u7 }" y+ i+ S; ]9 y" z- f57 Staphylococcus aureus vaccines 1161
# r1 q7 \$ d9 E5 k, m58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
  y0 ^2 q& r* @8 m60 Technologies for making new vaccines 1182
7 o) G- t3 ^  l  j1 K2 G. u1 ~61 Alternative vaccine delivery methods 1200
% i- x+ O% [* s  N/ ], Y62 The development of gene-based vectors for immunization 1232
6 R$ p* v& {: G" [! BSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
; c! `5 ~8 B, H+ q0 @7 C' D; x" M64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
( A* ^/ I- e" w" C66 Vaccines for health care personnel 1290
  z; {# j3 L4 g" |SECTION 5: Public health and regulatory issues
, P5 o5 k: }5 V67 Immunization in the United States 1310
68 Immunization in Europe . 1334
! [3 F2 F) X9 R% H9 H& ]69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
& C5 R3 G4 U- _3 l4 s: _" g7 d7 e74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
9 O# t  O/ M+ @; u+ p76 Vaccine safety 1464
77 Legal issues . 1481
% i* z6 {/ [2 |1 P78 Ethics 1508
8 k/ k: Y' k+ ?1 _" g

casarett

Vaccines, 6e, 2012

6 s- c- m. v9 v8 }& kHardcover: 1570 pages
3 \& l: n7 r+ [* j* wPublisher: Saunders; 6 edition (October 30, 2012)
8 J- r. o+ q; k$ N6 c1 }, QLanguage: English
ISBN-10: 1455700908
Size: 52.3mb (original pdf)

9 o1 _9 c6 N2 e# d7 k( d( F2013 BMA Medical Book Awards Highly Commended in Public Health!
6 t8 t+ g( c: u; t: m+ u9 TApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
2 H. _6 w/ \7 K& ~+ B3 s3 a
Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
, X3 x7 I+ p5 ?Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
2 k- P+ X1 I/ YGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
- j* h/ M, ]/ F  q+ tAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
& ~/ _6 s: B0 v2 J/ f7 z; hClearly visualize concepts and objective data through an abundance of tables and figures.
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
% q! {5 X, ?3 ?
2 F( G: x1 L* D6 M0 Y& W6 W) JDownload link: http://pan.baidu.com/s/1i5NxwLR
  l2 }" {  e9 F! y" n! Y. _! VCode for downloading: dv96
+ }# X7 D/ W+ e2 q; g* X